PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-3425

  1. 539 Posts.
    lightbulb Created with Sketch. 59
    This has to be good news for us, a qualified trial in horses that has led to FDA approval.
    Stack that up with dogs and humans on our side......

    I did find these comments a bit interesting and slightly humorous :

    HUMAN FOOD SAFETY
    "The product labeling contains the following Warning statement: Do not use in horses intended for human consumption."

    Exclusivity
    Zycosan™, as approved in our approval letter, qualifies for FIVE years of
    marketing exclusivity
    beginning as of the date of our approval letter. This drug
    qualifies for exclusivity under section 512(c)(2)(F)(i) of the FD&C Act because
    this is the first time we are approving this active moiety in a new animal drug
    application submitted under section 512(b)(1) of the FD&C Act.
    C. Patent Information
    For current information on patents, see the Green Book Reports in the Animal
    Drugs @ FDA database.

    USER SAFETY
    The product labeling contains the following information regarding safety to humans
    handling, administering, or exposed to Zycosan™:
    Not for use in humans. Keep out of reach of children. Pentosan polysulfate sodium is
    a weak anticoagulant. Caution should be used when administering Zycosan™ if you
    are taking an anticoagulant. In case of accidental self-injection, seek
    immediate medical attention. If product comes into contact with skin, rinse
    skin thoroughly with water and seek medical attention if needed.
    To obtain a
    Safety Data Sheet (SDS), contact Dechra at (866) 933-2472.

    All good - ours is ok for self-injection wink.png

    https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/13249
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
0.035(12.7%)
Mkt cap ! $108.4M
Open High Low Value Volume
27.5¢ 31.0¢ 27.5¢ $108.9K 371.2K

Buyers (Bids)

No. Vol. Price($)
1 1000 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 17420 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.